Articles Details

Making New Vaccines Affordable
Date: 09/08/2012

Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines (Lancet 2011; 378: 1885–93)

James R Hargreaves, Brian Greenwood, Charles Clift, Akshay Goel, Anne Roemer-Mahler, Richard Smith, David L Heymann.

Mechanisms to increase access to health products are varied and controversial. Two innovative mechanisms have been used to accelerate the development of low-price supply lines for conjugate vaccines. The Meningitis Vaccine Project is a so-called push mechanism that facilitated technology transfer to an Indian company to establish capacity to manufacture a vaccine. The Advanced Market Commitment for pneumococcal vaccines is a so-called pull mechanism that guarantees companies a supplement paid in addition to the purchase price for vaccines for a specific period. This paper compares these approaches, identifying key dimensions of each and considering their potential for replication.

For the complete article, write to us at

actostor vih actostudio actos
information on abortions go how much is an abortion pill
sulfasalazin penicillin sulfasalazin magen sulfasalazin forum